أعرض في EDS

5000 A 3-arm randomised phase II study of oral vinorelbine (NVBo) plus capecitabine (X) versus NVBo and X in sequential versus docetaxel (D) plus X in patients with metastatic breast cancer (MBC) previously treated with anthracyclines

التفاصيل البيبلوغرافية
العنوان:	5000 A 3-arm randomised phase II study of oral vinorelbine (NVBo) plus capecitabine (X) versus NVBo and X in sequential versus docetaxel (D) plus X in patients with metastatic breast cancer (MBC) previously treated with anthracyclines
المؤلفون:	S.J. Fourié, S. Tjulandin, J.C. Pouget, F. Lefresne, N. Dobrovolskaya, F. Mefti, Mario Campone, Jacek Jassem, M. Konstantinova, S.C. Chen
المصدر:	European Journal of Cancer Supplements. 7:259
بيانات النشر:	Elsevier BV, 2009.
سنة النشر:	2009
مصطلحات موضوعية:	Oncology, Cancer Research, medicine.medical_specialty, business.industry, Phases of clinical research, medicine.disease, Vinorelbine, Metastatic breast cancer, Capecitabine, Docetaxel, Internal medicine, Medicine, In patient, Previously treated, business, medicine.drug
تدمد:	1359-6349
DOI:	10.1016/s1359-6349(09)70892-4
URL الوصول:	https://explore.openaire.eu/search/publication?articleId=doi_________::20e3a2f2170514d80bb06e318ca454ee https://doi.org/10.1016/s1359-6349(09)70892-4
Rights:	OPEN
رقم الانضمام:	edsair.doi...........20e3a2f2170514d80bb06e318ca454ee
قاعدة البيانات:	OpenAIRE

الوصف
تدمد:	13596349
DOI:	10.1016/s1359-6349(09)70892-4